Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 55%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is expected to continue to grow due to their successful partnerships and evidence-based approach to healthcare, leading to increased revenue and a positive outlook. The company has a strong focus on chronic conditions, particularly diabetes, and has potential for future profits with expansion into Medicare and utilizing AI technology. However, potential changes in partnerships and the need for GLP-1 support may affect future growth and stock price.

Bears say

Omada Health is facing several challenges that could negatively impact its financial performance and stock price in the future. First, the company's revenue growth opportunities may be limited due to the growing complexity and cost of anti-obesity medications, which could hinder its ability to attract new customers. Second, while Omada has shown strong membership growth, it still only represents a small fraction of the potential market, indicating potential challenges in sustaining its current growth rate. Finally, the company's history of continued investments in its platform may limit its profitability in the short term, and it remains to be seen if these investments will result in sustainable long-term growth.

OMDA has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 55% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 11 analysts, OMDA has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.